EE411 Cost-Utility of Nabiximols for the Management of Spasticity Due to Multiple Sclerosis in Switzerland
Dec 1, 2022, 00:00
10.1016/j.jval.2022.09.657
https://www.valueinhealthjournal.com/article/S1098-3015(22)02861-3/fulltext
Title :
EE411 Cost-Utility of Nabiximols for the Management of Spasticity Due to Multiple Sclerosis in Switzerland
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(22)02861-3&doi=10.1016/j.jval.2022.09.657
First page :
Section Title :
Open access? :
No
Section Order :
10192